- Home
- FHTX vs INSE Comparison
FHTX vs INSE Comparison
Compare FHTX & INSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FHTX | INSE |
|---|---|---|
| Founded | 2015 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 332.2M | 230.5M |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FHTX | INSE |
|---|---|---|
| Price | $5.03 | $6.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 4 |
| Target Price | $11.50 | ★ $13.25 |
| AVG Volume (30 Days) | ★ 133.7K | 89.4K |
| Earning Date | 06-11-2026 | 06-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.32 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $30,909,000.00 | ★ $199,800,000.00 |
| Revenue This Year | $14.62 | N/A |
| Revenue Next Year | $15.27 | $2.68 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 36.75 | 30.25 |
| 52 Week Low | $2.94 | $6.51 |
| 52 Week High | $6.95 | $9.95 |
Technical Indicators
Market Signals| Indicator | FHTX | INSE |
|---|---|---|
| Relative Strength Index (RSI) | 39.18 | 31.80 |
| Support Level | $4.44 | N/A |
| Resistance Level | $5.85 | $9.69 |
| Average True Range (ATR) | 0.37 | 0.52 |
| MACD | -0.09 | -0.14 |
| Stochastic Oscillator | 30.17 | 17.17 |
Price Performance
Historical ComparisonAbout FHTX Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
About INSE Inspired Entertainment Inc.
Inspired Entertainment Inc is a gaming technology company based in the United States. Its core business involves the development of Virtual Sports and Server-Based Gaming systems with associated terminals and digital content to regulate betting, gaming, and lottery operators around the world. It operates through four segments, namely Gaming, Virtual Sports, Interactive, and Leisure. The company generates maximum revenue from the Gaming segment. Its Gaming segment supplies gaming terminals as well as gaming software and games for the terminals provided to betting offices, casinos, gaming halls, and high street adult gaming centers. Geographically, it derives a majority of revenue from the UK.